Immunological effects of recombinant interferon gamma in vivo in normal mice: failure to induce autoantibodies
- 1 January 1990
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 12 (6) , 691-698
- https://doi.org/10.1016/0192-0561(90)90107-x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Induction of antinuclear antibodies in patients with rheumatoid arthritis receiving treatment with human recombinant interferon gamma.Annals of the Rheumatic Diseases, 1988
- Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon-gammaInternational Journal of Cancer, 1988
- Quantitation and IgG subclass distribution of antichromatin autoantibodies in SLE miceClinical Immunology and Immunopathology, 1988
- Increased immunoglobulin response to γ-interferon by lymphocytes from patients with systemic lupus erythematosusClinical Immunology and Immunopathology, 1988
- In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.The Journal of Experimental Medicine, 1987
- Experimental autoimmune thyroiditis induced by recombinant interferon-γImmunology Today, 1987
- Analysis of the role of interferon‐gamma, interleukin 2 and a third factor distinct from interferon‐gamma and interleukin 2 on human B cell proliferation. Evidence that they act at different times after B cell activationEuropean Journal of Immunology, 1986
- Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon.The Journal of Experimental Medicine, 1985
- Immune interferon: a pleiotropic lymphokine with multiple effectsImmunology Today, 1985
- The basis of autoimmunity in MRL-lpr/lpr mice: a role for self Ia-reactive T cellsImmunology Today, 1984